What was NERVGEN PHARMA CORP. (NGEN)'s net income in fiscal 2025?

NERVGEN PHARMA CORP. (NGEN) reported net income of -CA$44.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -CA$24.3 million the year before. Source: the 40-F filed with the SEC on Mar 31, 2026.

NERVGEN PHARMA CORP.

NGEN · XNAS

CIK 1751912fmd_1A2A4ZS10CJN1R2TEGDPMFTBXYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2024 to Dec 31, 2025, 2 periods

Latest annual · FY2025

Millions

Net income: (44)

Open Financials

NERVGEN PHARMA CORP. (NGEN) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

Metric	FY2025	FY2024	Change	Source
Net income	-CA$44.1 million	-CA$24.3 million		40-F 2026-03-31 · proof

What was NERVGEN PHARMA CORP. (NGEN)'s net income in fiscal 2025?: NERVGEN PHARMA CORP. (NGEN) reported net income of -CA$44.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -CA$24.3 million the year before. Source: the 40-F filed with the SEC on Mar 31, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:NGEN&period_type=annual&limit=5"

Information only, not investment advice.